<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Braz. J. Microbiol</journal-id><journal-id journal-id-type="publisher-id">bjm</journal-id><journal-title-group><journal-title>Brazilian Journal of Microbiology</journal-title></journal-title-group><issn pub-type="ppub">1517-8382</issn><issn pub-type="epub">1678-4405</issn><publisher><publisher-name>Sociedade Brasileira de Microbiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26273253</article-id><article-id pub-id-type="pmc">4507530</article-id><article-id pub-id-type="doi">10.1590/S1517-838246220131278</article-id><article-categories><subj-group subj-group-type="heading"><subject>Environmental Microbiology</subject></subj-group></article-categories><title-group><article-title>Hypocholesterolemic effects of <italic>Kluyveromyces
marxianus</italic> M3 isolated from Tibetan mushrooms on diet-induced
hypercholesterolemia in rat</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Yuanhong</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Hongxing</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Hui</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref rid="c01" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Xiong</surname><given-names>Lixia</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Xiuzhi</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Jia</surname><given-names>Hui</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Lian</surname><given-names>Zhengxing</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Tong</surname><given-names>Nengsheng</given-names></name><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib></contrib-group><aff id="aff01"><label>1</label>Beijing Laboratory of Food Quality and
Safety, Faculty of Food Science and
Engineering, Beijing University of Agriculture, Beijing, China, Beijing Laboratory of Food Quality and Safety,
Faculty of Food Science and Engineering, Beijing University of Agriculture,
Beijing, China.</aff><aff id="aff02"><label>2</label>China Agriculture University, College of Animal Science &#x00026;
Technology, China Agricultural University, Beijing, China, College of Animal Science &#x00026; Technology,
China Agricultural University, Beijing, China.</aff><aff id="aff03"><label>3</label>Beijing China Investment Corporation Clinical
Laboratory, Beijing, China, Beijing China Investment Corporation Clinical
Laboratory, Beijing, China.</aff><author-notes><corresp id="c01">Send correspondence to H. Liu. Faculty of Food Science and
Engineering, Beijing University of Agriculture, No. 7 Bei Nong Road, ChangPing
District, 102206 Beijing, China. E-mail:
<email>foodlh@263.net</email>.</corresp><fn id="fn01" fn-type="other"><p>Associate Editor: Lara Dur&#x000e3;es Sette</p></fn></author-notes><pub-date pub-type="epub"><day>01</day><month>6</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2015</year></pub-date><volume>46</volume><issue>2</issue><fpage>389</fpage><lpage>395</lpage><history><date date-type="received"><day>03</day><month>12</month><year>2013</year></date><date date-type="accepted"><day>14</day><month>9</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015, Sociedade Brasileira de
Microbiologia</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>All the content of the journal, except where otherwise noted, is
licensed under a Creative Commons License CC BY-NC.</license-p></license></permissions><abstract><p>To investigate the effects of <italic>Kluyveromyces marxianus</italic> M3
isolated from Tibetan mushrooms on diet-induced hypercholesterolemia in rats,
female Wistar rats were fed a high-cholesterol diet (HCD) for 28 d to generate
hyperlipidemic models. Hyperlipidemic rats were assigned to four groups, which
were individually treated with three different dosages of <italic>K.
marxianus</italic> M3+HCD or physiological saline+HCD via oral gavage for 28
d. The total cholesterol (TC), triglycerides (TG), high-density lipoprotein
cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels in
the serum and liver of the rats were measured using commercially available
enzyme kits. In addition, the liver morphology was also examined using
hematoxylin and eosin staining and optical microscopy. According to our results,
the serum and liver TC, TG, LDL-C levels and atherogenic index (AI) were
significantly decreased in rats orally administered <italic>K.
marxianus</italic> M3 (p &#x0003c;0.01), and the HDL-C levels and anti
atherogenic index (AAI) were significantly increased (p &#x0003c;0.01) compared to
the control group. Moreover, <italic>K. marxianus</italic> M3 treatment also
reduced the build-up of lipid droplets in the liver and exhibited normal
hepatocytes, suggesting a protective effect of <italic>K. marxianus</italic> M3
in hyperlipidemic rats.</p></abstract><kwd-group><kwd><italic>Kluyveromyces marxianus</italic></kwd><kwd>hypercholesterolemia</kwd><kwd>high-cholesterol diet</kwd></kwd-group><counts><fig-count count="1"/><table-count count="3"/><equation-count count="0"/><ref-count count="45"/><page-count count="7"/></counts></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Hypercholesterolemia is considered to be a risk factor of cardiovascular disease and
is the leading cause of morbidity and mortality in many countries (<xref rid="B20" ref-type="bibr">Law <italic>et al.</italic>, 1994</xref>). Elevated serum
cholesterol levels are widely recognized as a contributing risk factor for the
development of cardiovascular diseases, such as atherosclerosis, coronary heart
disease and stroke. It has been reported that a 1% reduction in serum cholesterol
could reduce the risk of coronary heart disease by 2 to 3% (<xref rid="B26" ref-type="bibr">Manson <italic>et al.</italic>, 1992</xref>). The decrease in
cholesterol levels could be achieved by appropriate food intake, such as
low-cholesterol, low-fat diets (<xref rid="B25" ref-type="bibr">Lora <italic>et
al.</italic>, 2007</xref>), dietary fiber (<xref rid="B18" ref-type="bibr">Jim&#x000e9;nez <italic>et al.</italic>, 2008</xref>; <xref rid="B37" ref-type="bibr">Theuwissen <italic>et al.</italic>, 2008</xref>), and yogurts containing
specific probiotics (<xref rid="B01" ref-type="bibr">Akalin <italic>et al.</italic>,
1997</xref>; <xref rid="B09" ref-type="bibr">Danielson <italic>et al.</italic>,
1989</xref>).</p><p>Recently, some studies have demonstrated that the hypocholesterolemic effects of
probiotics have resulted in an increased interest in this treatment modality, which
is less expensive and may be considered a "natural health remedy." Several studies
evaluating this effect have found that some <italic>lactobacilli</italic> or
<italic>bifidobacteria</italic> can exhibit hypocholesterolemic properties in
animal models (<xref rid="B13" ref-type="bibr">Fukushima and Nakano 1996</xref>;
Gilliland <italic>et al.</italic>, 1989; <xref rid="B29" ref-type="bibr">Nguyen
<italic>et al.</italic>, 2007</xref>; <xref rid="B19" ref-type="bibr">Kumar
<italic>et al.</italic>, 2011</xref>) and humans (<xref rid="B04" ref-type="bibr">Agerbaek <italic>et al.</italic>, 1995</xref>; <xref rid="B06" ref-type="bibr">Anderson and Gilliland 1999</xref>; <xref rid="B41" ref-type="bibr">Xiao <italic>et al.</italic>, 2003</xref>). However, the
hypocholesterolemic mechanism of lactic acid bacteria is still no clearly
understood, although the bacteria appear to contribute to increased fecal excretion
of bile acids and thereby improved overall hepatic cholesterol homeostasis (<xref rid="B17" ref-type="bibr">Jeun <italic>et al.</italic>, 2010</xref>). Moreover,
some reports have failed to show hypocholesterolemic effects of probiotics (<xref rid="B16" ref-type="bibr">Hatakka <italic>et al.</italic>, 2008</xref>; <xref rid="B33" ref-type="bibr">Simons <italic>et al.</italic>, 2006</xref>). Thus,
additional studies are required to strengthen the proposed hypotheses and to improve
our understanding of how bacteria affect cholesterol metabolism, which might result
in the more appropriate use of probiotics.</p><p>Kefir has been widely recommended in western countries for consumption by healthy
people to lower the risk of chronic diseases and has also been provided to some
patients for the clinical treatment of a number of gastrointestinal and metabolic
diseases, hypertension, and allergy (<xref rid="B36" ref-type="bibr">St-Onge
<italic>et al.</italic>, 2002</xref>). Yogurt prepared from Tibetan
mushrooms and milk has an extraordinary taste and provides excellent nutrition.
Tibetan kefir has a granular structure due to the presence of symbiotic
microorganisms, such as <italic>Lactobacillus</italic> and yeast (<xref rid="B35" ref-type="bibr">Simova <italic>et al.</italic>, 2002</xref>). In addition, kefir
culture was reported to exhibit the ability to assimilate cholesterol in milk (<xref rid="B38" ref-type="bibr">Vujicic <italic>et al.</italic>, 1992</xref>).
Furthermore, <xref rid="B24" ref-type="bibr">Liu <italic>et al.</italic>
(2006)</xref> demonstrated the hypocholesterolemic effect of kefir milk in male
hamsters fed with a cholesterol-enriched diet. However, <xref rid="B36" ref-type="bibr">St-Onge <italic>et al.</italic> (2002)</xref> obtained a
conflicting result and reported that kefir consumption did not result in the
lowering of plasma lipid concentrations, although kefir resulted in increasing fecal
isobutyric, isovaleric, and propionic acids as well as the total amount of fecal
short chain fatty acids.</p><p>Moreover, some researchers have found that kefir-fermented milk can decrease plasma
cholesterol levels and can promote cancer resistance. Furthermore, it has
antioxidant properties, including a role in immune regulation, and can help to
protect against pathogenic bacteria and spoilage organisms, as well as assist in the
conservation of predominant gastrointestinal probiotic flora (<xref rid="B02" ref-type="bibr">Abd El-Gawad <italic>et al.</italic>, 2005</xref>; <xref rid="B27" ref-type="bibr">Mathara <italic>et al.</italic>, 2008</xref>; <xref rid="B29" ref-type="bibr">Nguyen <italic>et al.</italic>, 2007</xref>; <xref rid="B01" ref-type="bibr">Akalin <italic>et al.</italic>, 1997</xref>). The
objective of this study was to evaluate the effects of <italic>Kluyveromyces
marxianus</italic> M3 yeast isolated from Tibetan mushrooms on lowering
cholesterol in rats.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Microbial cultures</title><p>
<italic>K. marxianus</italic> M3 was isolated from Tibetan mushrooms and was
cultured by a resident of Baicheng, Jilin province, China (<xref rid="B23" ref-type="bibr">Liu <italic>et al.</italic>, 2005</xref>). M3 strains (1&#x02013;2%)
were inoculated into 10 mL potato lactose liquid medium and grown at 28 &#x000b0;C for
24. The culture was centrifuged and diluted with 0.9% saline water to obtain a
preparation of 2.0 &#x000d7; 10<sup>7</sup> cfu/mL.</p></sec><sec><title>Animals, diets and experimental design</title><p>Forty female Wistar rats (aged 3 weeks) with a weight of 140 &#x000b1; 10 g were obtained
from the Academy of Military Medical Sciences (Beijing, China). All rats were
individually housed at a constant temperature and humidity (18&#x02013;24 &#x000b0;C, 60%) with
a 12 h light/dark cycle. After 1 week of acclimatization, all of the rats were
fed a high-cholesterol diet (78.8% basic diet, 1% cholesterol, 10% egg yolk, 10%
lard, 0.2% cholate, w/w) for 28 d. In addition, the rats were randomly assigned
to four groups (n = 10), respectively. Group (NM): normal rats fed a standard
high-cholesterol diet and physiological saline (5 mL/kg); Group &#x003b1; (LD): normal
rats fed a standard high-cholesterol diet and <italic>K. marxianus</italic> M3
(5 mL/kg); Group &#x003b2; (MD): normal rats fed a standard high-cholesterol diet and
<italic>K. marxianus</italic> M3 (10 mL/kg); Group IV (HD): normal rats fed
a standard high-cholesterol diet and <italic>K. marxianus</italic> M3 (20
mL/kg).</p><p>The rats were intragastrically administered for 28 d, and food and water
consumption and body weight were recorded daily. At the end of the feeding
period, all rats were anesthetized by isoflurane and sacrificed by cervical
dislocation. The kidney, heart and liver were immediately excised, and the serum
was separated from the blood. The liver, heart and kidney were excised, rinsed
in ice-cold physiological saline, weighed, and then stored at &#x02212;20 &#x000b0;C.</p></sec><sec><title>Serum lipid analysis</title><p>The samples were allowed to stand for 10 min and then centrifuged at 3500 r/min
for 15 min, where the sediment was subsequently discarded. The TC (total
cholesterol), TG (triglyceride), HDL-C (high density lipoprotein-cholesterol),
and LDL-C (low density lipoprotein-cholesterol) levels were analyzed using kits
(Bio-technology and Science Incorporation) and a fully automatic biochemical
analyzer (Hitachi, Japan). The atherosclerosis index (AI) was calculated as
follows: AI = (total cholesterol - HDL cholesterol)/HDL cholesterol.</p></sec><sec><title>Liver lipid analysis</title><p>Isolated livers were weighed after rinsing with phosphate-buffered saline and
blotted dry with filter paper. Each liver was homogenized in 20 volumes of
extraction solution (chloroform: methanol = 2:1; v/v) and agitated for 60 min at
room temperature (<xref rid="B45" ref-type="bibr">Zhao <italic>et al.</italic>,
2012</xref>). Liver cholesterol and triacylglycerols were measured using the
kits previously described.</p></sec><sec><title>Morphology of liver</title><p>Fresh livers of rats were fixed with 4% paraformaldehyde for 24 h, gradually
dehydrated in a graded series of ethanol, clarified in xylene, and embedded in
paraffin wax. The hematoxylin and eosin stained livers were observed using an
optical microscope (<xref rid="B39" ref-type="bibr">Wang <italic>et
al.</italic>, 2013</xref>).</p></sec><sec><title>Statistical analysis</title><p>All data were expressed as the mean &#x000b1; SD. Statistical analysis was performed
using SPSS 13.0 software. Differences between the groups were analyzed by
One-Way ANOVA followed by Duncan's multiple range tests. Statistical
significance was considered at p &#x0003c;0.01.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Effect on plasma lipid profiles</title><p>The effects of <italic>K. marxianus</italic> M3 live yeast supplementation on the
serum lipid levels of rats are presented in <xref rid="t01" ref-type="table">Table 1</xref>. The rats subjected to a high cholesterol diet or high
cholesterol diet with <italic>K. marxianus</italic> M3 had no obvious difference
in body weight (BW) during the entire 7 weeks of experiments. And high
cholesterol diet dramatically increased the serum TC, TG and LDL-C levels of
rats in NM group, which demonstrated the hyperlipidemic model was set up
successfully. In addition, oral administration of <italic>K. marxianus</italic>
M3 for 7 weeks significantly decreased (p &#x0003c;0.01) the serum TC, TG and LDL-C
levels of rats compared with the NM groups. In contrast, the serum HDL-C levels
in the <italic>K. marxianus</italic> M3 supplemented rats significantly
increased (p &#x0003c;0.01, p &#x0003c;0.05) compared to that in NM group after 7 weeks of
administration.</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><title>Effect of <italic>Kluyveromyces marxianus</italic> M3 from Tibetan
Kefir on plasma lipid profiles of rats ( &#x000b1; s, n = 6).</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th colspan="4" valign="bottom" align="center" rowspan="1">NM</th><th colspan="4" valign="bottom" align="center" rowspan="1">LD</th><th colspan="4" valign="bottom" align="center" rowspan="1">MD</th><th colspan="4" valign="bottom" align="center" rowspan="1">HD</th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th colspan="4" valign="bottom" align="left" rowspan="1">
<hr/>
</th><th colspan="4" valign="bottom" align="left" rowspan="1">
<hr/>
</th><th colspan="4" valign="bottom" align="left" rowspan="1">
<hr/>
</th><th colspan="4" valign="bottom" align="left" rowspan="1">
<hr/>
</th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">1 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">3 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">5 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">7 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">1 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">3 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">5 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">7 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">1 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">3 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">5 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">7 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">1 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">3 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">5 week</th><th valign="bottom" align="center" rowspan="1" colspan="1">7 week</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">BW (g)</td><td valign="top" align="center" rowspan="1" colspan="1">155.1 &#x000b1; 5.1</td><td valign="top" align="center" rowspan="1" colspan="1">204.9 &#x000b1; 9.9</td><td valign="top" align="center" rowspan="1" colspan="1">251.9 &#x000b1; 16.9</td><td valign="top" align="center" rowspan="1" colspan="1">273.2 &#x000b1; 20.8</td><td valign="top" align="center" rowspan="1" colspan="1">154.3 &#x000b1; 7.3</td><td valign="top" align="center" rowspan="1" colspan="1">204.4 &#x000b1; 11.6</td><td valign="top" align="center" rowspan="1" colspan="1">246.4 &#x000b1; 14.6</td><td valign="top" align="center" rowspan="1" colspan="1">268.1 &#x000b1; 20.9</td><td valign="top" align="center" rowspan="1" colspan="1">156.2 &#x000b1; 6.8</td><td valign="top" align="center" rowspan="1" colspan="1">206.5 &#x000b1; 10.5</td><td valign="top" align="center" rowspan="1" colspan="1">244.1 &#x000b1; 15.9</td><td valign="top" align="center" rowspan="1" colspan="1">268.3 &#x000b1; 21.3</td><td valign="top" align="center" rowspan="1" colspan="1">155.4 &#x000b1; 8.6</td><td valign="top" align="center" rowspan="1" colspan="1">205.5 &#x000b1; 12.5</td><td valign="top" align="center" rowspan="1" colspan="1">247.3 &#x000b1; 17.3</td><td valign="top" align="center" rowspan="1" colspan="1">272.2 &#x000b1; 21.2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">TC (mmol/L)</td><td valign="top" align="center" rowspan="1" colspan="1">2.86 &#x000b1; 0.96</td><td valign="top" align="center" rowspan="1" colspan="1">3.18 &#x000b1; 1.06</td><td valign="top" align="center" rowspan="1" colspan="1">4.76 &#x000b1; 1.50</td><td valign="top" align="center" rowspan="1" colspan="1">4.94 &#x000b1; 1.90</td><td valign="top" align="center" rowspan="1" colspan="1">2.84 &#x000b1; 0.75</td><td valign="top" align="center" rowspan="1" colspan="1">3.07 &#x000b1; 0.95</td><td valign="top" align="center" rowspan="1" colspan="1">3.36 &#x000b1; 1.26<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">2.75 &#x000b1; 0.76<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">2.72 &#x000b1; 0.70</td><td valign="top" align="center" rowspan="1" colspan="1">3.34 &#x000b1; 1.35</td><td valign="top" align="center" rowspan="1" colspan="1">3.39 &#x000b1; 1.41<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">2.42 &#x000b1; 0.62<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">2.58 &#x000b1; 0.60</td><td valign="top" align="center" rowspan="1" colspan="1">3.81 &#x000b1; 1.43</td><td valign="top" align="center" rowspan="1" colspan="1">4.10 &#x000b1; 1.82</td><td valign="top" align="center" rowspan="1" colspan="1">3.17 &#x000b1; 1.09<xref rid="TFN03" ref-type="table-fn">**</xref>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">TG (mmol/L)</td><td valign="top" align="center" rowspan="1" colspan="1">0.39 &#x000b1; 0.23</td><td valign="top" align="center" rowspan="1" colspan="1">0.24 &#x000b1; 0.20</td><td valign="top" align="center" rowspan="1" colspan="1">0.37 &#x000b1; 0.12</td><td valign="top" align="center" rowspan="1" colspan="1">0.51 &#x000b1; 0.23</td><td valign="top" align="center" rowspan="1" colspan="1">0.30 &#x000b1; 0.15</td><td valign="top" align="center" rowspan="1" colspan="1">0.25 &#x000b1; 0.18</td><td valign="top" align="center" rowspan="1" colspan="1">0.33 &#x000b1; 0.09</td><td valign="top" align="center" rowspan="1" colspan="1">0.31 &#x000b1; 0.07<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.37 &#x000b1; 0.21</td><td valign="top" align="center" rowspan="1" colspan="1">0.41 &#x000b1; 0.28</td><td valign="top" align="center" rowspan="1" colspan="1">0.37 &#x000b1; 0.11</td><td valign="top" align="center" rowspan="1" colspan="1">0.36 &#x000b1; 0.12<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.33 &#x000b1; 0.12</td><td valign="top" align="center" rowspan="1" colspan="1">0.19 &#x000b1; 0.13</td><td valign="top" align="center" rowspan="1" colspan="1">0.34 &#x000b1; 0.12</td><td valign="top" align="center" rowspan="1" colspan="1">0.33 &#x000b1; 0.12<xref rid="TFN03" ref-type="table-fn">**</xref>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HDL-C (mmol/L)</td><td valign="top" align="center" rowspan="1" colspan="1">0.70 &#x000b1; 0.16</td><td valign="top" align="center" rowspan="1" colspan="1">0.48 &#x000b1; 0.06</td><td valign="top" align="center" rowspan="1" colspan="1">0.45 &#x000b1; 0.08</td><td valign="top" align="center" rowspan="1" colspan="1">0.43 &#x000b1; 0.14</td><td valign="top" align="center" rowspan="1" colspan="1">0.70 &#x000b1; 0.15</td><td valign="top" align="center" rowspan="1" colspan="1">0.60 &#x000b1; 0.20</td><td valign="top" align="center" rowspan="1" colspan="1">0.52 &#x000b1; 0.10</td><td valign="top" align="center" rowspan="1" colspan="1">0.62 &#x000b1; 0.18<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.64 &#x000b1; 0.14</td><td valign="top" align="center" rowspan="1" colspan="1">0.51 &#x000b1; 0.17</td><td valign="top" align="center" rowspan="1" colspan="1">0.46 &#x000b1; 0.10</td><td valign="top" align="center" rowspan="1" colspan="1">0.50 &#x000b1; 0.17<xref rid="TFN02" ref-type="table-fn">DD</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.58 &#x000b1; 0.14</td><td valign="top" align="center" rowspan="1" colspan="1">0.52 &#x000b1; 0.17</td><td valign="top" align="center" rowspan="1" colspan="1">0.40 &#x000b1; 0.10</td><td valign="top" align="center" rowspan="1" colspan="1">0.45 &#x000b1; 0.10<xref rid="TFN02" ref-type="table-fn">DD</xref>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">LDL-C (mmol/L)</td><td valign="top" align="center" rowspan="1" colspan="1">0.64 &#x000b1; 0.20</td><td valign="top" align="center" rowspan="1" colspan="1">1.04 &#x000b1; 0.37</td><td valign="top" align="center" rowspan="1" colspan="1">1.57 &#x000b1; 0.51</td><td valign="top" align="center" rowspan="1" colspan="1">1.58 &#x000b1; 0.61</td><td valign="top" align="center" rowspan="1" colspan="1">0.65 &#x000b1; 0.20</td><td valign="top" align="center" rowspan="1" colspan="1">0.82 &#x000b1; 0.25</td><td valign="top" align="center" rowspan="1" colspan="1">0.69 &#x000b1; 0.34<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.63 &#x000b1; 0.33<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.56 &#x000b1; 0.16</td><td valign="top" align="center" rowspan="1" colspan="1">1.04 &#x000b1; 0.43</td><td valign="top" align="center" rowspan="1" colspan="1">0.74 &#x000b1; 0.47<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.88 &#x000b1; 0.41<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.64 &#x000b1; 0.17</td><td valign="top" align="center" rowspan="1" colspan="1">0.94 &#x000b1; 0.54</td><td valign="top" align="center" rowspan="1" colspan="1">0.95 &#x000b1; 0.58<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">1.08 &#x000b1; 0.41<xref rid="TFN03" ref-type="table-fn">**</xref>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">AI</td><td valign="top" align="center" rowspan="1" colspan="1">2.85 &#x000b1; 0.35</td><td valign="top" align="center" rowspan="1" colspan="1">5.67 &#x000b1; 0.53</td><td valign="top" align="center" rowspan="1" colspan="1">10.11 &#x000b1; 0.96</td><td valign="top" align="center" rowspan="1" colspan="1">10.11 &#x000b1; 0.91</td><td valign="top" align="center" rowspan="1" colspan="1">3.01 &#x000b1; 0.24</td><td valign="top" align="center" rowspan="1" colspan="1">4.01 &#x000b1; 0.34</td><td valign="top" align="center" rowspan="1" colspan="1">5.67 &#x000b1; 0.52<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">3.35 &#x000b1; 0.25<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">3.17 &#x000b1; 0.26</td><td valign="top" align="center" rowspan="1" colspan="1">5.67 &#x000b1; 0.51</td><td valign="top" align="center" rowspan="1" colspan="1">6.14 &#x000b1; 0.46<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">4.00 &#x000b1; 0.25<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">3.55 &#x000b1; 0.21</td><td valign="top" align="center" rowspan="1" colspan="1">6.14 &#x000b1; 0.46</td><td valign="top" align="center" rowspan="1" colspan="1">10.00 &#x000b1; 0.90</td><td valign="top" align="center" rowspan="1" colspan="1">6.14 &#x000b1; 0.74<xref rid="TFN03" ref-type="table-fn">**</xref>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">AII</td><td valign="top" align="center" rowspan="1" colspan="1">0.26 &#x000b1; 0.03</td><td valign="top" align="center" rowspan="1" colspan="1">0.15 &#x000b1; 0.02</td><td valign="top" align="center" rowspan="1" colspan="1">0.09 &#x000b1; 0.01</td><td valign="top" align="center" rowspan="1" colspan="1">0.09 &#x000b1; 0.01</td><td valign="top" align="center" rowspan="1" colspan="1">0.25 &#x000b1; 0.04</td><td valign="top" align="center" rowspan="1" colspan="1">0.20 &#x000b1; 0.03</td><td valign="top" align="center" rowspan="1" colspan="1">0.15 &#x000b1; 0.02<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.23 &#x000b1; 0.04<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.24 &#x000b1; 0.04</td><td valign="top" align="center" rowspan="1" colspan="1">0.15 &#x000b1; 0.02</td><td valign="top" align="center" rowspan="1" colspan="1">0.14 &#x000b1; 0.02<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.20 &#x000b1; 0.04<xref rid="TFN03" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.22 &#x000b1; 0.05</td><td valign="top" align="center" rowspan="1" colspan="1">0.14 &#x000b1; 0.02</td><td valign="top" align="center" rowspan="1" colspan="1">0.10 &#x000b1; 0.01</td><td valign="top" align="center" rowspan="1" colspan="1">0.14 &#x000b1; 0.01<xref rid="TFN03" ref-type="table-fn">**</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="TFN01"><p>Data represent mean &#x000b1; SD (n = 6 for each group). <sup>1</sup>BW: body
weight (g), <sup>2</sup>AI = (TC-HDL-C)/HDL-C,
<sup>3</sup>AAI=HDL-C/TC. TC: Total cholesterol; TG: Triglyceride;
HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density
lipoprotein cholesterol; AI: Atherogenic index; AAI: Anti
atherogenic index; NM: High-cholesterol diet group; LD:
High-cholesterol diet with Low dosage of <italic>K.
marxianus</italic> M3 group; MD: High-cholesterol diet with
middle dosage of <italic>K. marxianus</italic> M3 group; HD:
High-cholesterol diet with high dosage of <italic>K.
marxianus</italic> M3 group.</p></fn><fn id="TFN02"><label>DD</label><p>p &#x0003c;0.05 compared with the control group;</p></fn><fn id="TFN03"><label>**</label><p>p &#x0003c;0.01 compared with the control group.</p></fn></table-wrap-foot></table-wrap><p>Moreover, oral administration of various dosages of <italic>K. marxianus</italic>
M3 showed different degrees of changes in serum lipid. The serum TC, TG, and
LDL-C levels were the most reduced in the LD group, decreasing by 44.33%, 39.21%
and 60.12%, respectively, whereas the serum HDL-C level improved by 44.18%
compared to the NM group. In the MD group, the serum TC, TG, and LDL-C levels
decreased by 51.01%, 29.41% and 44.3%, respectively, whereas the HDL-C level
improved by 16.27%. Moreover, the serum levels of TC, TG and LDL-C in the HD
group were decreased by 35.82%, 35.29% and 31.64%, respectively, and the HDL-C
level increased by 4.65% (<xref rid="t01" ref-type="table">Table 1</xref>). As a
result, oral administration of <italic>K. marxianus</italic> M3 in rats
significantly decreased (p &#x0003c;0.01) the serum TC, TG, LDL-C levels and
atherogenic index (AI), and significantly increased (p &#x0003c;0.01) the serum HDL-C
levels and anti-atherogenic index (AAI) compared to the NM group.</p></sec><sec><title>Effect on Liver lipid profiles</title><p>After 7 weeks of treatment, the liver lipid levels of rats were also examined. As
shown in <xref rid="t02" ref-type="table">Table 2</xref>, oral administration of
<italic>K. marxianus</italic> M3 for 7 weeks significantly decreased (p
&#x0003c;0.01) liver TC, TG, LDL-C levels and the AI compared with the NM groups. In
addition, the liver HDL-C levels and AII of the <italic>K. marxianus</italic> M3
treatment group were significantly higher (p &#x0003c;0.01) compared to the NM group.
Moreover, oral administration of <italic>K. marxianus</italic> M3 at various
dosages showed different degrees of decreases in liver TC, TG, LDL-C levels and
increases in liver HDL-C levels. After 7 weeks of administration, the liver TG,
TC, LDL-C levels in the MD group significantly decreased (p &#x0003c;0.01) by 36.00%,
22.92% and 52.94% compared with the NM group. Furthermore, the liver HDL-C
contents in the LD group rats reached 0.31 &#x000b1; 0.10 mmol/L, which was 72.22%
higher than that in the NM group. As a result, <italic>K. marxianus</italic> M3
treatment in the LD group significantly decreased (p &#x0003c;0.01) the liver AI and
increased (p &#x0003c;0.01) the liver AII compared with the NM group.</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><title>Effect of Kluyveromyces marxianus from Tibetan Kefir on hepatic lipid
profiles of rats ( &#x000b1; s, n = 10).</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">TC (mmol/L)</th><th valign="bottom" align="center" rowspan="1" colspan="1">TG (mmol/L)</th><th valign="bottom" align="center" rowspan="1" colspan="1">HDL-C (mmol/L)</th><th valign="bottom" align="center" rowspan="1" colspan="1">LDL-C (mmol/L)</th><th valign="bottom" align="center" rowspan="1" colspan="1">AI</th><th valign="bottom" align="center" rowspan="1" colspan="1">AAI</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">NM</td><td valign="top" align="center" rowspan="1" colspan="1">0.25 &#x000b1; 0.07</td><td valign="top" align="center" rowspan="1" colspan="1">0.48 &#x000b1; 0.09</td><td valign="top" align="center" rowspan="1" colspan="1">0.18 &#x000b1; 0.07</td><td valign="top" align="center" rowspan="1" colspan="1">0.17 &#x000b1; 0.13</td><td valign="top" align="center" rowspan="1" colspan="1">0.37 &#x000b1; 0.07</td><td valign="top" align="center" rowspan="1" colspan="1">0.73 &#x000b1; 0.11</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">LD</td><td valign="top" align="center" rowspan="1" colspan="1">0.16 &#x000b1; 0.05<xref rid="TFN06" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.37 &#x000b1; 0.07<xref rid="TFN06" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.31 &#x000b1; 0.10<xref rid="TFN06" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.08 &#x000b1; 0.05<xref rid="TFN06" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.50 &#x000b1; 0.07<xref rid="TFN06" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">2.11 &#x000b1; 0.11<xref rid="TFN06" ref-type="table-fn">**</xref>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MD</td><td valign="top" align="center" rowspan="1" colspan="1">0.19 &#x000b1; 0.04<xref rid="TFN06" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.42 &#x000b1; 0.11<xref rid="TFN05" ref-type="table-fn">DD</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.27 &#x000b1; 0.11<xref rid="TFN06" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.13 &#x000b1; 0.04<xref rid="TFN05" ref-type="table-fn">DD</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.32 &#x000b1; 0.04<xref rid="TFN06" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">1.51 &#x000b1; 0.09<xref rid="TFN06" ref-type="table-fn">**</xref>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HD</td><td valign="top" align="center" rowspan="1" colspan="1">0.20 &#x000b1; 0.05<xref rid="TFN06" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.41 &#x000b1; 0.08<xref rid="TFN05" ref-type="table-fn">DD</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.25 &#x000b1; 0.13<xref rid="TFN06" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.14 &#x000b1; 0.05<xref rid="TFN05" ref-type="table-fn">DD</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.23 &#x000b1; 0.06<xref rid="TFN06" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">1.33 &#x000b1; 0.10<xref rid="TFN06" ref-type="table-fn">**</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="TFN04"><p>Data represent mean &#x000b1; SD (n = 10 for each group). AI =
(TC-HDL-C)/HDL-C, AAI=HDL-C/TC. TC: Total cholesterol; TG:
Triglyceride; HDL-C: High-density lipoprotein cholesterol; LDL-C:
Low-density lipoprotein cholesterol; AI: Atherogenic index; AAI:
Anti atherogenic index; NM: High-cholesterol diet group; LD:
High-cholesterol diet with Low dosage of <italic>K.
marxianus</italic> M3 group; MD: High-cholesterol diet with
middle dosage of <italic>K. marxianus</italic> M3 group; HD:
High-cholesterol diet with high dosage of <italic>K.
marxianus</italic> M3 group.</p></fn><fn id="TFN05"><label>DD</label><p>p &#x0003c;0.05 compared with the control group;</p></fn><fn id="TFN06"><label>**</label><p>p &#x0003c;0.01 compared with the control group.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Effects on viscera organs</title><p>As shown in <xref rid="t03" ref-type="table">Table 3</xref>, a high cholesterol
diet increased the heart, liver and kidney weight of the rats. After 7 weeks of
administration, the viscera weight (heart, liver and kidney weight) and viscera
coefficients in the rats of the LD group were significantly lower (p &#x0003c;0.01)
compare to the NM group. The heart weight, heart coefficient, liver weight and
liver coefficient in the MD and HD groups were also significantly decreased (p
&#x0003c;0.01) compared to the NM group. Moreover, the kidney weight and kidney
coefficient in the MD and HD groups were significantly decreased (p &#x0003c;0.05)
compared to the NM group.</p><table-wrap id="t03" orientation="portrait" position="float"><label>Table 3</label><caption><title>Effect of <italic>Kluyveromyces marxianus</italic> from Tibetan Kefir
on visceral weight and visceral coefficient of rats ( &#x000b1; s, n =
10).</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">Heart weight (g)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Cardiac coefficient (%)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Liver weight (g)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Liver coefficient (%)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Renal weight (g)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Renal coefficient (%)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">NM</td><td valign="top" align="center" rowspan="1" colspan="1">1.28 &#x000b1; 0.17</td><td valign="top" align="center" rowspan="1" colspan="1">0.48 &#x000b1; 0.04</td><td valign="top" align="center" rowspan="1" colspan="1">12.56 &#x000b1; 1.72</td><td valign="top" align="center" rowspan="1" colspan="1">4.81 &#x000b1; 0.21</td><td valign="top" align="center" rowspan="1" colspan="1">1.73 &#x000b1; 0.17</td><td valign="top" align="center" rowspan="1" colspan="1">0.64 &#x000b1; 0.06</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">LD</td><td valign="top" align="center" rowspan="1" colspan="1">0.81 &#x000b1; 0.11<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.28 &#x000b1; 0.02<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">8.86 &#x000b1; 1.14<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">3.24 &#x000b1; 0.14<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">1.47 &#x000b1; 0.11<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.54 &#x000b1; 0.04<xref rid="TFN09" ref-type="table-fn">**</xref>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MD</td><td valign="top" align="center" rowspan="1" colspan="1">0.85 &#x000b1; 0.15<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.30 &#x000b1; 0.03<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">9.23 &#x000b1; 1.37<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">3.43 &#x000b1; 0.17<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">1.54 &#x000b1; 0.14<xref rid="TFN08" ref-type="table-fn">DD</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.57 &#x000b1; 0.02<xref rid="TFN08" ref-type="table-fn">DD</xref>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HD</td><td valign="top" align="center" rowspan="1" colspan="1">0.87 &#x000b1; 0.13<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.33 &#x000b1; 0.04<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">9.31 &#x000b1; 1.21<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">3.45 &#x000b1; 0.16<xref rid="TFN09" ref-type="table-fn">**</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">1.60 &#x000b1; 0.18<xref rid="TFN08" ref-type="table-fn">DD</xref>
</td><td valign="top" align="center" rowspan="1" colspan="1">0.60 &#x000b1; 0.03<xref rid="TFN08" ref-type="table-fn">DD</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="TFN07"><p>Data represent mean &#x000b1; SD (n = 10 for each group). Cardiac coefficient
= heart weight/body weight; Liver coefficient = liver weight/body
weight; Renal coefficient = renal weight/body weight; NM:
High-cholesterol diet group; LD: High-cholesterol diet with Low
dosage of <italic>K. marxianus</italic> M3 group; MD:
High-cholesterol diet with middle dosage of <italic>K.
marxianus</italic> M3 group; HD: High-cholesterol diet with high
dosage of <italic>K. marxianus</italic> M3 group.</p></fn><fn id="TFN08"><label>DD</label><p>p &#x0003c;0.05 compared with the control group;</p></fn><fn id="TFN09"><label>**</label><p>p &#x0003c;0.01 compared with the control group.</p></fn></table-wrap-foot></table-wrap><p>We further examined the hepatic morphology in rats. As shown in <xref rid="f01" ref-type="fig">Figure 1a</xref>, in the NM group rats, the structure of the
hepatic lobule had disappeared, and the liver cell morphology was irregular.
There were different degrees of edema, focal necrosis, and fatty degeneration of
liver cells. Moreover, the liver cells exhibited massive fatty changes and
severe steatosis with cytoplasmic vacuoles, and the infiltration of inflammatory
cells were visible. Taken together, these conditions suggested damage due to a
high-cholesterol diet on the hepatic cells. In contrast, the size of the lipid
droplets in the LD group was remarkably smaller than those in the NM group
(<xref rid="f01" ref-type="fig">Figure 1b</xref>), and the hepatic cells
exhibited normal histology. In addition, the lipid droplets in the MD and HD
groups were also reduced in varying degrees (<xref rid="f01" ref-type="fig">Figure 1c, d</xref>). Taken together, our results indicated that <italic>K.
marxianus</italic> M3 treatment reduced the build-up of lipid droplets and
maintained normal hepatocytes.</p><fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Histology of liver steatosis in rats. A: high-cholesterol diet group;
B: high-cholesterol diet+<italic>K. marxianus</italic> M3 (5 mL/kg); C:
high-cholesterol diet+<italic>K. marxianus</italic> M3 (10 mL/kg); D:
high-cholesterol diet+<italic>K. marxianus</italic> M3 (20 mL/kg). All
the photomicrographs show HE staining (original magnification &#x000d7;
100).</title></caption><graphic xlink:href="1517-8382-bjm-46-2-389-gf01"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Recently, considerable attention has focused on the potential of probiotics in
altering lipid metabolism. This interest stems from growing evidence that probiotics
reduce the concentration of cholesterol in vivo (<xref rid="B28" ref-type="bibr">Mohan <italic>et al.</italic>, 1995</xref>; <xref rid="B03" ref-type="bibr">Abdulrahim <italic>et al.</italic>, 1996</xref>; <xref rid="B30" ref-type="bibr">Panda <italic>et al.</italic>, 2003</xref>; <xref rid="B29" ref-type="bibr">Nguyen <italic>et al.</italic>, 2007</xref>; <xref rid="B40" ref-type="bibr">Wang <italic>et al.</italic>, 2009</xref>; <xref rid="B05" ref-type="bibr">Alkhalf <italic>et al.</italic>, 2010</xref>; <xref rid="B39" ref-type="bibr">Wang <italic>et al.</italic>, 2013</xref>). Generally, a
high-cholesterol diet can increase body weight (<xref rid="B42" ref-type="bibr">Xie
<italic>et al.</italic>, 2011</xref>). According to our results, addition of
<italic>K. marxianus</italic> M3 live yeast with high-cholesterol diet did not
significantly change the body weight of rats. However, <italic>K. marxianus</italic>
M3 treatment for 7 weeks significantly decreased (p &#x0003c;0.01) the serum TC, TG and
LDL-C levels in rats. In particular, these effects were more evident in the LD group
(TC, TG and LDL-C reduced by 51.01%, 39.22% and 60.13%, respectively) (<xref rid="t01" ref-type="table">Table 1</xref>). Our results indicated that there was
a relationship between the formation and reduction of the metabolism of cholesterol
in the serum. Similar results were reported for the cholesterol-reducing activity of
yeast (<xref rid="B43" ref-type="bibr">Yal&#x000e7;in <italic>et al.</italic>, 2008</xref>;
<xref rid="B44" ref-type="bibr">Yal&#x000e7;in <italic>et al.</italic>, 2009</xref>),
<italic>Lactobacillus</italic> (<xref rid="B14" ref-type="bibr">Nielson and
Gilliland, 1985</xref>, <xref rid="B14" ref-type="bibr">Gilliland <italic>et
al.</italic>, 1985</xref>; <xref rid="B15" ref-type="bibr">Hashimoto
<italic>et al.</italic>, 1999</xref>; <xref rid="B33" ref-type="bibr">Simons
<italic>et al.</italic>, 2006</xref>; <xref rid="B29" ref-type="bibr">Nguyen
<italic>et al.</italic>, 2007</xref>; <xref rid="B42" ref-type="bibr">Xie
<italic>et al.</italic>, 2011</xref>; <xref rid="B39" ref-type="bibr">Wang
<italic>et al.</italic>, 2013</xref>) and <italic>Bacillus</italic> (<xref rid="B12" ref-type="bibr">Fukushima and Nakao, 1995</xref>).</p><p>High concentrations of TC and LDL-C are strongly associated with an increased risk of
coronary heart disease. A reduction in TC and LDL-C in a hypercholesterolemic
individual can reduce the incidence of cardiovascular disease (<xref rid="B32" ref-type="bibr">Probstfield and Rifkind 1991</xref>). Moreover, elevated levels
of oxidized LDL-C are associated with artherosclerotic plaque formation on the
artery walls, but increased HDL-C levels may reduce the risk due to the ability of
HDL to transport cholesterol back to the liver for excretion or to other tissues of
cardiovascular disease (<xref rid="B21" ref-type="bibr">Lewis <italic>et
al.</italic>, 2005</xref>). According to our results, <italic>K.
marxianus</italic> M3 supplementation dramatically increased the serum HDL-C
level (p &#x0003c;0.01, p &#x0003c;0.05) in rats (<xref rid="t01" ref-type="table">Table
1</xref>). As a result, the AI of the <italic>K. marxianus</italic> M3 treatment
groups was significantly decreased (p &#x0003c;0.01) compared to the NM group. Thus, we
confirmed that <italic>K. marxianus</italic> M3 exerted a hypolipidemic effect and
could alleviate lipid related metabolic syndrome. Similar results were reported by
<xref rid="B15" ref-type="bibr">Hashimoto <italic>et al.</italic> (1999)</xref>,
in which a diet containing <italic>L. casei</italic> TMC 0409 increased the
concentration of HDL-C in blood, which was consistent with other studies (<xref rid="B01" ref-type="bibr">Akalin <italic>et al.</italic>, 1997</xref>; <xref rid="B09" ref-type="bibr">Danielson <italic>et al.</italic>, 1989</xref>; <xref rid="B11" ref-type="bibr">De Smet <italic>et al.</italic>, 1998</xref>).
However, conflicting results were reported (<xref rid="B08" ref-type="bibr">Chiu
<italic>et al.</italic>, 2006</xref>; <xref rid="B36" ref-type="bibr">St-Onge <italic>et al.</italic>, 2002</xref>; Keim <italic>et al.</italic>,
1981, Rossouw <italic>et al.</italic>, 1981; <xref rid="B10" ref-type="bibr">De Roos
<italic>et al.</italic>, 1998</xref>) in humans and animals.</p><p>In general, cholesterol is indispensable to the human body, and its levels are
subjected to complex regulation. Cholesterol is modified into oxysterols, including
22- and 24-hydroxy cholesterol, when excess cholesterol is deposited in hepatic
cells (<xref rid="B34" ref-type="bibr">Satoshi Hirako <italic>et al.</italic>,
2011</xref>). As expected, we demonstrated that the high-cholesterol diet
increased hepatic TC, TG and LDL-C levels in rats (<xref rid="t02" ref-type="table">Table 2</xref>). Rats supplemented with <italic>K. marxianus</italic> M3
displayed significant reductions in hepatic TC, TG and LDL-C levels. These findings
demonstrated that the serum cholesterol and TG levels in <italic>K.
marxianus</italic> M3-treated rats were reduced, rather than merely being
redistributed from the blood to the liver. Moreover, our results were consistent
with previous reports (<xref rid="B19" ref-type="bibr">Kumar <italic>et
al.</italic>, 2011</xref>; <xref rid="B08" ref-type="bibr">Chiu <italic>et
al.</italic>, 2006</xref>).</p><p>In this study, a high-cholesterol diet promoted the visceral weight (heart, liver and
renal) in rats (<xref rid="t03" ref-type="table">Table 3</xref>). In addition, oral
administration of <italic>K. marxianus</italic> M3 significantly reduced the
visceral weights and visceral coefficients, suggesting a protection of <italic>K.
marxianus</italic> M3 to the visceral organs under a high-cholesterol diet.
Moreover, the histology of liver steatosis also supported this result.
High-cholesterol diet caused different degrees of edema, focal necrosis, and fatty
degeneration of liver cells (<xref rid="f01" ref-type="fig">Figure 1a</xref>). In
contrast, the <italic>K. marxianus</italic> M3 treatment could reduce the build-up
of lipid droplets and maintained normal hepatocytes (<xref rid="f01" ref-type="fig">Figure 1b, c</xref>). The result of liver tectology proved that the <italic>K.
marxianus</italic> M3 had important potential in alleviating hepatic steatosis
attributed to mediation of lipid metabolism and had protective effects on hepatic
structure. Similar results have also been reported (<xref rid="B39" ref-type="bibr">Wang <italic>et al.</italic>, 2013</xref>; <xref rid="B42" ref-type="bibr">Xie
<italic>et al.</italic>, 2011</xref>).</p><p>In recent yeas, several hypotheses have been proposed to explain the
hypocholesterolemic effects of the probiotic strains: (1) consumption or absorption
of cholesterol by probiotic strains (<xref rid="B31" ref-type="bibr">Pigeon
<italic>et al.</italic>, 2002</xref>; <xref rid="B22" ref-type="bibr">Liong
and Shah 2005</xref>); (2) the cholesterol is converted into coprostanol by
cholesterol reductase, which is produced by probiotic strains (Lye <italic>et
al.</italic>, 2010); (3) some probiotic strains excrete bile salt hydrolase,
leading to increased bile excretion in feces (Begley <italic>et al.</italic>, 2010),
etc. There are some reports on bile salt hydrolase in different species of
<italic>Lactobacillus</italic>, <italic>Enterococcus</italic>,
<italic>Peptostreptococcus</italic>, <italic>Bifidobacterium</italic>,
<italic>Clostridium</italic>, and <italic>Bacteroides</italic> (<xref rid="B22" ref-type="bibr">Liong and Shah 2005</xref>; Begley <italic>et al.</italic>,
2010). In our previous research, we have cloned the bile salt hydrolase
(<italic>bsh</italic>) gene in <italic>K. marxianus</italic> (Genebank Acession:
JQ247427.1). So we proposed that the hypocholesterolemic effects of <italic>K.
marxianus</italic> M3 might cased by the activity of bile salt hydrolase. And
further research could be conduct in this field.</p><p>In conclusion, our results suggested that <italic>K. marxianus</italic> M3 is a safe
probiotic with the potential to reduce serum cholesterol and triglyceride levels.
Thus, further studies are required to determine the mechanism underlying the
cholesterol-lowering effect. It will also be necessary to test more animals,
utilizing varying doses of <italic>K. marxianus</italic> M3 over longer time
periods, to assess the long-term probiotic potential of <italic>K.
marxianus</italic> M3.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported financially by The Comprehensive Reforming Project to promote
talents training of BUA, Disease Resistance Transgenic Sheep and Breeding of New
Breeds (2013ZX08008-005) and the Key Construction Discipline Program of Beijing
Municipal Commission of Education (PXM2014-014207-0000029).</p></ack><ref-list><title>References</title><ref id="B01"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akalin</surname><given-names>AS</given-names></name><name><surname>G&#x000f6;n&#x000e7;</surname><given-names>S</given-names></name><name><surname>D&#x000fc;zel</surname><given-names>S</given-names></name></person-group><year>1997</year><article-title>Influence of yogurt and acidophilus yogurt on serum cholesterol
levels in mice</article-title><source>J Dairy Sci</source><volume>80</volume><fpage>2721</fpage><lpage>2725</lpage><pub-id pub-id-type="pmid">9406066</pub-id></element-citation></ref><ref id="B02"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abd El-Gawad</surname><given-names>IA</given-names></name><name><surname>El-Sayed</surname><given-names>E</given-names></name><name><surname>Hafez</surname><given-names>S</given-names></name><etal/></person-group><year>2005</year><article-title>The hypocholesterolaemic effect of milk yoghurt and soy-yoghurt
containing bifidobacteria in rats fed on a cholesterol-enriched
diet</article-title><source>Int Dairy J</source><volume>15</volume><fpage>37</fpage><lpage>44</lpage></element-citation></ref><ref id="B03"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdulrahim</surname><given-names>SM</given-names></name><name><surname>Haddadin</surname><given-names>SY</given-names></name><name><surname>Hashlamoun</surname><given-names>EA</given-names></name><etal/></person-group><year>1996</year><article-title>The influence of <italic>Lactobacillus acidophilus</italic> and
bacitracin on layer performance of chickens and cholesterol content of
plasma and egg yolk</article-title><source>Br Poult Sci</source><volume>37</volume><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">8773843</pub-id></element-citation></ref><ref id="B04"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agerbaek</surname><given-names>M</given-names></name><name><surname>Gerdes</surname><given-names>LU</given-names></name><name><surname>Richelsen</surname><given-names>B</given-names></name></person-group><year>1995</year><article-title>Hypocholesterolaemic effect of a new fermented milk product in
healthy middle-aged men</article-title><source>Eur J Clin Nutr</source><volume>49</volume><fpage>346</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">7664720</pub-id></element-citation></ref><ref id="B05"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkhalf</surname><given-names>A</given-names></name><name><surname>Alhaj</surname><given-names>M</given-names></name><name><surname>Al-Homidan</surname><given-names>I</given-names></name></person-group><year>2010</year><article-title>Influence of probiotic supplementation on blood parameters and
growth performance in broiler chickens</article-title><source>Saudi J Biol Sci</source><volume>17</volume><fpage>219</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">23961081</pub-id></element-citation></ref><ref id="B06"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JW</given-names></name><name><surname>Gilliland</surname><given-names>SE</given-names></name></person-group><year>1999</year><article-title>Effect of fermented milk (yogurt) containing
<italic>Lactobacillus acidophilus</italic> L1 on serum cholesterol in
hypercholesterolemic humans</article-title><source>J Am Coll Nutr</source><volume>18</volume><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">10067658</pub-id></element-citation></ref><ref id="B07"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Begley</surname><given-names>M</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Gahan</surname><given-names>CG</given-names></name></person-group><year>2006</year><article-title>Bile salt hydrolase activity in probiotics</article-title><source>Appl Environ Microbiol</source><volume>72</volume><fpage>1729</fpage><lpage>1738</lpage><pub-id pub-id-type="pmid">16517616</pub-id></element-citation></ref><ref id="B08"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>CH</given-names></name><name><surname>Lu</surname><given-names>TY</given-names></name><name><surname>Tseng</surname><given-names>YY</given-names></name><etal/></person-group><year>2006</year><article-title>The effects of <italic>Lactobacillus</italic>-fermented milk on
lipid metabolism in hamsters fed on high cholesterol diet</article-title><source>Appl Microbiol Biotechnol</source><volume>71</volume><fpage>238</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">16172889</pub-id></element-citation></ref><ref id="B09"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danielson</surname><given-names>AD</given-names></name><name><surname>Peo</surname><given-names>ERJ</given-names></name><name><surname>Shahani</surname><given-names>KM</given-names></name><etal/></person-group><year>1989</year><article-title>Anticholesterolemic property of <italic>Lactobacillus
acidophilus</italic> yoghurt fed to mature boars</article-title><source>J Anim Sci</source><volume>67</volume><fpage>966</fpage><lpage>974</lpage><pub-id pub-id-type="pmid">2497098</pub-id></element-citation></ref><ref id="B10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Roos</surname><given-names>NM</given-names></name><name><surname>Schouten</surname><given-names>G</given-names></name><name><surname>Katan</surname><given-names>MB</given-names></name></person-group><year>1998</year><article-title>Yoghurt enriched with <italic>Lactobacillus acidophilus</italic>
does not lower blood lipids in healthy men and women with normal to
borderline high serum cholesterol levels</article-title><source>Eur J Clin Nutr</source><volume>53</volume><fpage>277</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">10334653</pub-id></element-citation></ref><ref id="B11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Smet</surname><given-names>I</given-names></name><name><surname>De Boever</surname><given-names>P</given-names></name><name><surname>Versteaete</surname><given-names>W</given-names></name></person-group><year>1998</year><article-title>Cholesterol lowering in pigs through enhanced bacterial bile salt
hydrolase activity</article-title><source>Br J Nutr</source><volume>79</volume><fpage>185</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">9536863</pub-id></element-citation></ref><ref id="B12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukushima</surname><given-names>M</given-names></name><name><surname>Nakano</surname><given-names>M</given-names></name></person-group><year>1995</year><article-title>The effect of a probiotic on faecal and liver lipid classes in
rats</article-title><source>Br J Nutr</source><volume>73</volume><fpage>701</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">7626589</pub-id></element-citation></ref><ref id="B13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukushima</surname><given-names>M</given-names></name><name><surname>Nakano</surname><given-names>M</given-names></name></person-group><year>1996</year><article-title>Effects of a mixture of organisms, <italic>Lactobacillus
acidophilus</italic> or <italic>Streptococcus faecalis</italic> on
cholesterol metabolism in rats fed on a fat- and cholesterol-enriched
diet</article-title><source>Br J Nutr</source><volume>76</volume><fpage>857</fpage><lpage>867</lpage><pub-id pub-id-type="pmid">9014654</pub-id></element-citation></ref><ref id="B14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilliland</surname><given-names>SE</given-names></name><name><surname>Nelson</surname><given-names>CR</given-names></name><name><surname>Maxwell</surname><given-names>C</given-names></name></person-group><year>1985</year><article-title>Assimilation of cholesterol by <italic>Lactobacillus
acidophilus</italic>
</article-title><source>Appl Environ Microb</source><volume>49</volume><fpage>377</fpage><lpage>381</lpage></element-citation></ref><ref id="B15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>H</given-names></name><name><surname>Yamazaki</surname><given-names>K</given-names></name><name><surname>He</surname><given-names>F</given-names></name><etal/></person-group><year>1999</year><article-title>Hypocholesterolemic effects of <italic>Lactobacillus
casei</italic> subsp. <italic>casei</italic> TMC 0409 strain observed in
rats fed cholesterol contained diets</article-title><source>Anim Sci J</source><volume>72</volume><fpage>90</fpage><lpage>97</lpage></element-citation></ref><ref id="B16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatakka</surname><given-names>K</given-names></name><name><surname>Mutanen</surname><given-names>M</given-names></name><name><surname>Holma</surname><given-names>R</given-names></name><etal/></person-group><year>2008</year><article-title>
<italic>Lactobacillus rhamnosus</italic> LC705 together with
<italic>Propionibacterium freudenreichii</italic> ssp shermanii JS
administered in capsules is ineffective in lowering serum
lipids</article-title><source>J Am Coll Nutr</source><volume>27</volume><fpage>441</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">18978162</pub-id></element-citation></ref><ref id="B17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeun</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Cho</surname><given-names>SY</given-names></name><etal/></person-group><year>2010</year><article-title>Hypocholesterolemic effects of <italic>Lactobacillus
plantarum</italic> KCTC3928 by increased bile acid excretion in C57BL/6
mice</article-title><source>Nutrition</source><volume>26</volume><fpage>321</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">19695834</pub-id></element-citation></ref><ref id="B18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez</surname><given-names>JP</given-names></name><name><surname>Serrano</surname><given-names>J</given-names></name><name><surname>Tabernero</surname><given-names>M</given-names></name><etal/></person-group><year>2008</year><article-title>Effects of grape antioxidant dietary fiber in cardiovascular
disease risk factors</article-title><source>Nutrition</source><volume>24</volume><fpage>646</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">18485668</pub-id></element-citation></ref><ref id="B19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Grover</surname><given-names>S</given-names></name><name><surname>Batish</surname><given-names>VK</given-names></name></person-group><year>2011</year><article-title>Hypocholesterolaemic effect of dietary inclusion of two putative
probiotic bile salt hydrolase-producing <italic>Lactobacillus
plantarum</italic> strains in Sprague-Dawley rats</article-title><source>Brit J Nutr</source><volume>105</volume><fpage>561</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">20923582</pub-id></element-citation></ref><ref id="B20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>MR</given-names></name><name><surname>Wald</surname><given-names>NJ</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><etal/></person-group><year>1994</year><article-title>Systematic underestimation of association between serum
cholesterol concentration and ischaemic heart disease in observational
studies: Data from the BUPA study</article-title><source>BMJ</source><volume>308</volume><fpage>363</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">8124143</pub-id></element-citation></ref><ref id="B21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>GF</given-names></name><name><surname>Rader</surname><given-names>DJ</given-names></name></person-group><year>2005</year><article-title>New insights into the regulation of HDL metabolism and reverse
cholesterol transport</article-title><source>Circ Res</source><volume>96</volume><fpage>1221</fpage><lpage>1232</lpage><pub-id pub-id-type="pmid">15976321</pub-id></element-citation></ref><ref id="B22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liong</surname><given-names>MT</given-names></name><name><surname>Shah</surname><given-names>NP</given-names></name></person-group><year>2005</year><article-title>Bile salt deconjugation and BSH activity of five bifidobacterial
strains and their cholesterol co-precipitating properties</article-title><source>Food Res Int</source><volume>38</volume><fpage>135</fpage><lpage>142</lpage></element-citation></ref><ref id="B23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Dong</surname><given-names>R</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><etal/></person-group><year>2005</year><article-title>Optimization of fermentation conditions of <italic>Kluyveromyces
marxianus</italic> bile salt hydrolase</article-title><source>Food Science</source><volume>26</volume><fpage>97</fpage><lpage>100</lpage><comment>(In Chinese)</comment></element-citation></ref><ref id="B24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JR</given-names></name><name><surname>Wang</surname><given-names>SY</given-names></name><name><surname>Chen</surname><given-names>MJ</given-names></name><etal/></person-group><year>2006</year><article-title>Hypocholesterolaemic effects of milk-kefir and soyamilk-kefir in
cholesterol-fed hamsters</article-title><source>Br J Nutr</source><volume>95</volume><fpage>939</fpage><lpage>946</lpage><pub-id pub-id-type="pmid">16611384</pub-id></element-citation></ref><ref id="B25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lora</surname><given-names>KR</given-names></name><name><surname>Morse</surname><given-names>KL</given-names></name><name><surname>Gonzalez-Kruger</surname><given-names>GE</given-names></name><etal/></person-group><year>2007</year><article-title>High saturated fat and cholesterol intakes and abnormal plasma
lipid concentrations observed in a group of 4- to 8-year-old children of
Latino immigrants in rural Nebraska</article-title><source>Nutr Res</source><volume>27</volume><fpage>483</fpage><lpage>491</lpage></element-citation></ref><ref id="B26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Tosteson</surname><given-names>H</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><etal/></person-group><year>1992</year><article-title>The primary prevention of myocardial infarction</article-title><source>N Engl J Med</source><volume>326</volume><fpage>1406</fpage><lpage>1416</lpage><pub-id pub-id-type="pmid">1533273</pub-id></element-citation></ref><ref id="B27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathara</surname><given-names>JM</given-names></name><name><surname>Schillinger</surname><given-names>U</given-names></name><name><surname>Guigas</surname><given-names>C</given-names></name><etal/></person-group><year>2008</year><article-title>Functional characteristics of <italic>Lactobacillus</italic> spp.
from traditional Maasai fermented milk products in Kenya</article-title><source>Int J Food Microbiol</source><volume>126</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">18539351</pub-id></element-citation></ref><ref id="B28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>B</given-names></name><name><surname>Kadirvel</surname><given-names>R</given-names></name><name><surname>Bhaskaran</surname><given-names>M</given-names></name><etal/></person-group><year>1995</year><article-title>Effect of probiotic supplementation on serum/yolk cholesterol and
on egg shell thickness in layers</article-title><source>Br Poult Sci</source><volume>36</volume><fpage>799</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">8746981</pub-id></element-citation></ref><ref id="B29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>TD</given-names></name><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name></person-group><year>2007</year><article-title>Characterization of <italic>Lactobacillus plantarum</italic>
PH04, a potential probiotic bacterium with cholesterol-lowering
effects</article-title><source>Int J Food Microbiol</source><volume>113</volume><fpage>358</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">17140690</pub-id></element-citation></ref><ref id="B30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname><given-names>AK</given-names></name><name><surname>Reddy</surname><given-names>MR</given-names></name><name><surname>Rama Rao</surname><given-names>SV</given-names></name><etal/></person-group><year>2003</year><article-title>Production performance, serum/yolk cholesterol and immune
competence of white leghorn layers as influenced by dietary supplementation
with probiotic</article-title><source>Trop Anim Health Prod</source><volume>35</volume><fpage>85</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">12636363</pub-id></element-citation></ref><ref id="B31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pigeon</surname><given-names>RM</given-names></name><name><surname>Cuesta</surname><given-names>EP</given-names></name><name><surname>Gililliand</surname><given-names>SE</given-names></name></person-group><year>2002</year><article-title>Binding of free bile acids by cells of yogurt starter culture
bacteria</article-title><source>J Dairy Sci</source><volume>85</volume><fpage>2705</fpage><lpage>2710</lpage><pub-id pub-id-type="pmid">12487437</pub-id></element-citation></ref><ref id="B32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Probstfield</surname><given-names>JL</given-names></name><name><surname>Rifkind</surname><given-names>BM</given-names></name></person-group><year>1991</year><article-title>The lipid research clinics coronary primary prevention trial:
Design, results, and implications</article-title><source>Eur J Clin Pharmacol</source><volume>40</volume><fpage>S69</fpage><lpage>S75</lpage><pub-id pub-id-type="pmid">2044648</pub-id></element-citation></ref><ref id="B33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>LA</given-names></name><name><surname>Amansec</surname><given-names>SG</given-names></name><name><surname>Conway</surname><given-names>P</given-names></name></person-group><year>2006</year><article-title>Effect of <italic>Lactobacillus</italic> fermentum on serum
lipids in subjects with elevated serum cholesterol</article-title><source>Nutr Metab Cardiovasc Dis</source><volume>16</volume><fpage>531</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">17126768</pub-id></element-citation></ref><ref id="B34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoshi</surname><given-names>H</given-names></name><name><surname>Hyoun-Ju</surname><given-names>K</given-names></name><name><surname>Saya</surname><given-names>S</given-names></name><etal/></person-group><year>2011</year><article-title>Low-Dose fish oil consumption prevents hepatic lipid accumulation
in high cholesterol diet fed mice</article-title><source>J Agric Food Chem</source><volume>59</volume><fpage>13353</fpage><lpage>13359</lpage><pub-id pub-id-type="pmid">22066791</pub-id></element-citation></ref><ref id="B35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simova</surname><given-names>E</given-names></name><name><surname>Beshkova</surname><given-names>D</given-names></name><name><surname>Angelov</surname><given-names>A</given-names></name><etal/></person-group><year>2002</year><article-title>Lactic acid bacteria and yeasts in kefir grains and kefir made
from them</article-title><source>J Ind Microbiol Biotechnol</source><volume>28</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11938463</pub-id></element-citation></ref><ref id="B36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St-Onge</surname><given-names>MP</given-names></name><name><surname>Farnworth</surname><given-names>ER</given-names></name><name><surname>Savard</surname><given-names>T</given-names></name><etal/></person-group><year>2002</year><article-title>Kefir consumption does not alter plasma lipid levels or
cholesterol fractional synthesis rates relative to milk in hyperlipidemic
men: a randomized controlled trial</article-title><source>BMC Complement Altern Med</source><volume>2</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11825344</pub-id></element-citation></ref><ref id="B37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theuwissen</surname><given-names>E</given-names></name><name><surname>Mensink</surname><given-names>RP</given-names></name></person-group><year>2008</year><article-title>Water-soluble dietary fibers and cardiovascular
disease</article-title><source>Physiol Behav</source><volume>94</volume><fpage>285</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">18302966</pub-id></element-citation></ref><ref id="B38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vujicic</surname><given-names>IF</given-names></name><name><surname>Vulic</surname><given-names>M</given-names></name><name><surname>Konyves</surname><given-names>T</given-names></name></person-group><year>1992</year><article-title>Assimilation of cholesterol in milk by kefir
cultures</article-title><source>Biotechnol Lett</source><volume>14</volume><fpage>847</fpage><lpage>850</lpage></element-citation></ref><ref id="B39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>LX</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Gao</surname><given-names>DW</given-names></name><etal/></person-group><year>2013</year><article-title>Protective effects of two <italic>Lactobacillus
plantarum</italic> strains in hyperlipidemic mice</article-title><source>World J Gastroenterol</source><volume>19</volume><fpage>3150</fpage><lpage>3156</lpage><pub-id pub-id-type="pmid">23716997</pub-id></element-citation></ref><ref id="B40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>N</given-names></name><name><surname>Xi</surname><given-names>A</given-names></name><etal/></person-group><year>2009</year><article-title>Effects of <italic>Lactobacillus plantarum</italic> MA2 isolated
from Tibet kefir on lipid metabolism and intestinal microflora of rats fed
on high-cholesterol diet</article-title><source>Appl Microbiol Biotechnol</source><volume>84</volume><fpage>341</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">19444443</pub-id></element-citation></ref><ref id="B41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>JZ</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><etal/></person-group><year>2003</year><article-title>Effects of milk products fermented by <italic>Bifidobacterium
longum</italic> on blood lipids in rats and healthy adult male
volunteers</article-title><source>J Dairy Sci</source><volume>86</volume><fpage>2452</fpage><lpage>2461</lpage><pub-id pub-id-type="pmid">12906063</pub-id></element-citation></ref><ref id="B42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>N</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>YN</given-names></name><etal/></person-group><year>2011</year><article-title>Effects of two <italic>Lactobacillus</italic> strains on lipid
metabolism and intestinal microflora in rats fed a high-cholesterol
diet</article-title><source>BMC Complement Altern Med</source><volume>11</volume><fpage>53</fpage><pub-id pub-id-type="pmid">21722398</pub-id></element-citation></ref><ref id="B43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yal&#x000e7;in</surname><given-names>S</given-names></name><name><surname>Erol</surname><given-names>H</given-names></name><name><surname>Ozsoy</surname><given-names>B</given-names></name><etal/></person-group><year>2008</year><article-title>Effects of the usage of dried brewing yeast in the diets on the
performance, egg traits and blood parameters in quails</article-title><source>Animal</source><volume>2</volume><fpage>1780</fpage><lpage>1785</lpage><pub-id pub-id-type="pmid">22444084</pub-id></element-citation></ref><ref id="B44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yal&#x000e7;in</surname><given-names>S</given-names></name><name><surname>Oguz</surname><given-names>F</given-names></name><name><surname>G&#x000fc;&#x000e7;l&#x000fc;</surname><given-names>B</given-names></name><etal/></person-group><year>2009</year><article-title>Effects of dietary dried baker's yeast on the performance, egg
traits and blood parameters in laying quails</article-title><source>Trop Anim Health Prod</source><volume>41</volume><fpage>5</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">19052896</pub-id></element-citation></ref><ref id="B45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Higashikawa</surname><given-names>F</given-names></name><name><surname>Noda</surname><given-names>M</given-names></name><etal/></person-group><year>2012</year><article-title>The obesity and fatty liver are reduced by plant-derived
<italic>Pediococcus pentosaceus</italic> LP28 in high fat diet-induced
obese mice</article-title><source>PLoS One</source><volume>7</volume><fpage>e30696</fpage><pub-id pub-id-type="pmid">22363472</pub-id></element-citation></ref></ref-list></back></article>